Basic Information
| LncRNA/CircRNA Name | UBE2Q1-AS1 |
| Synonyms | NA |
| Region | GRCh38_1:154553609-154555017 |
| Ensemble | ENSG00000229780 |
| Refseq | NR_046668 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | Microarray, qPCR |
| Sample | GEO |
| Expression Pattern | up-regulated |
| Function Description | lncRNA UBE2Q1-AS1, upregulated, and significantly related to tumor grade in GC.UBE2Q1-AS1 mainly participates in ubiquitin-mediated proteolysis and RNA degradation, perhaps indicating a potential role in GC. |
| Pubmed ID | 31934786 |
| Year | 2020 |
| Title | Comprehensive Analysis of lncRNAs Associated With the Pathogenesis and Prognosis of Gastric Cancer |
External Links
| Links for UBE2Q1-AS1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |